Literature DB >> 9219195

Incorporating risk attitude into Markov-process decision models: importance for individual decision making.

D J Cher1, J Miyamoto, L A Lenert.   

Abstract

Most decision models published in the medical literature take a risk-neutral perspective. Under risk neutrality, the utility of a gamble is equivalent to its expected value and the marginal utility of living a given unit of time is the same regardless of when it occurs. Most patients, however, are not risk-neutral. Not only does risk aversion affect decision analyses when tradeoffs between short- and long-term survival are involved, it also affects the interpretation of time-tradeoff measures of health-state utility. The proportional time tradeoff under- or overestimates the disutility of an inferior health state, depending on whether the patient is risk-seeking or risk-averse (it is unbiased if the patient is risk-neutral). The authors review how risk attitude with respect to gambles for survival duration can be incorporated into decision models using the framework of risk-adjusted quality-adjusted life years (RA-QALYs). They present a simple extension of this framework that allows RA-QALYs to be calculated for Markov-process decision models. Using a previously published Markov-process model of surgical vs expectant treatment for benign prostatic hypertrophy (BPH), they show how attitude towards risk affects the expected number of QALYs calculated by the model. In this model, under risk neutrality, surgery was the preferred option. Under mild risk aversion, expectant treatment was the preferred option. Risk attitude is an important aspect of preferences that should be incorporated into decision models where one treatment option has upfront risks of morbidity or mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9219195     DOI: 10.1177/0272989X9701700311

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  13 in total

Review 1.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Engaging patients in medical decision making.

Authors:  R L Kravitz; J Melnikow
Journal:  BMJ       Date:  2001-09-15

3.  Exponential health utility. A characterization and comments on the contribution by Happich and Muhlbacher.

Authors:  Lars Peter Osterdal
Journal:  Eur J Health Econ       Date:  2004-12

4.  Predictors of risk tolerance among oral surgery patients.

Authors:  Kathryn A Atchison; Claudia Der-Martirosian; Thomas R Belin; Edward E Black; Melanie W Gironda
Journal:  J Oral Maxillofac Surg       Date:  2010-08-03       Impact factor: 1.895

5.  Women's views of two interventions designed to assist in the prophylactic oophorectomy decision: a qualitative pilot evaluation.

Authors:  Vanita Bhavnani; Aileen Clarke; Jack Dowie; Andrew Kennedy; Ian Pell
Journal:  Health Expect       Date:  2002-06       Impact factor: 3.377

6.  Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.

Authors:  Leif-Erik D Schumacher; Alan Dal Pra; Sarah E Hoffe; Eric A Mellon
Journal:  Br J Radiol       Date:  2020-08-12       Impact factor: 3.039

7.  Development and preliminary evaluation of a clinical guidance programme for the decision about prophylactic oophorectomy in women undergoing a hysterectomy.

Authors:  I Pell; J Dowie; A Clarke; A Kennedy; V Bhavnani
Journal:  Qual Saf Health Care       Date:  2002-03

8.  Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement.

Authors:  Maggie N Tillquist; Thomas M Maddox
Journal:  Patient Prefer Adherence       Date:  2011-02-17       Impact factor: 2.711

9.  Patient preference and willingness to pay for knee osteoarthritis treatments.

Authors:  John Posnett; Sanjeev Dixit; Brooks Oppenheimer; Sven Kili; Nazanin Mehin
Journal:  Patient Prefer Adherence       Date:  2015-06-11       Impact factor: 2.711

10.  Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis.

Authors:  Monica Ortendahl
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.